facebook

twitter

youtube

linkedin

Home - News and Events - News - The Hidden Costs of Rare Diseases, a feasibility study

December 01 2016

The Hidden Costs of Rare Diseases, a feasibility study

SHARE

Genetik Alliance UK has conducted a study on the hidden costs of Rare Diseases, assessing how best to measure and evaluate the true costs of managing rare conditions.

More info here

Read the full report here

what-is-cadasil-webinar-vascern-thumbnail

Webinar Replay: Spectrum of Clinical Manifestations in CADASIL with Prof. Hugues Chabriat

CPMS 2.0 Mobile App Launch

CPMS 2.0 Mobile App Launch

Not just a nosebleed - HHT Day Graphic

World HHT Day 2025 – See Beyond

ERDERA-NSS-2025

ERDERA launches €30K networking scheme for rare disease research

ERDERA launches patient survey on rare disease research involvement

BEE meeting 2025

Key takeaways from the BEE Meeting 2025 on Hereditary Haemorrhagic Telangiectasia

Inside the HHT Working Group Spring Meeting 2025

Seventy-seventh World Health Assembly, Geneva, Switzerland, 27 May - 1 June 2024

WHA resolution on rare diseases officially adopted by WHO

22nd CG Meeting

VASCERN presents the summer school initiative at the 22nd ERNs coordinator group meeting